Skip to content

Saliva and serum concentrations of fluconazole in children

Saliva and serum concentrations of fluconazole in children - Saliva and serum concentrations of fluconazole in children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON31910
Enrollment
32
Registered
2008-12-11
Start date
2008-06-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

(invasive) Candida infection yeast infection

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: Included are children on oral (with of without enteral tube) or intravenous fluconazole treatment.

Exclusion criteria

Exclusion criteria: Excluded are children from whom it is impossible to get saliva ,or who have, due to their condition, such a serious mucositis of their oral cavity that saliva is mixed with blood, are excluded.

Design outcomes

Primary

MeasureTime frame
-pharmacokinetics of fluconazole in saliva and serum in children and neonates -fluconazole saliva/serum concentration ratio in children and neonates.

Secondary

MeasureTime frame
-Efficacy of fluconazole treatment, as measured by negative (surveillance-)cultures. -Does fluconazole reach sufficient levels in the gastrointestinal tract when the administration route is intravenous

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)